Yesintek 90 mg inj. sol. s.c. pre-filled pen 1 ml
Active ingredient: Ustekinumab
View notice details →News topic
ATC group L04AC05
Current shortage notices for the ATC group L04AC05, structured by product, country and reporting period.
8 noticesYesintek 45 mg inj. sol. s.c. pre-filled pen 0.5 ml
Active ingredient: Ustekinumab
View notice details →Yesintek 45 mg inj. sol. s.c. pre-filled pen 0.5 ml
Active ingredient: Ustekinumab
View notice details →Usymro 90 mg inj. sol. s.c. pre-filled syr. 1 ml
Active ingredient: Ustekinumab
View notice details →Usymro 45 mg inj. sol. s.c. pre-filled syr. 0.5 ml
Active ingredient: Ustekinumab
View notice details →Usymro 90 mg inj. sol. s.c. pre-filled syr. 1 ml
Active ingredient: Ustekinumab
View notice details →Usymro 45 mg inj. sol. s.c. pre-filled syr. 0.5 ml
Active ingredient: Ustekinumab
View notice details →Imuldosa 130 mg inf. sol. (conc.) i.v. vial 26 ml
Active ingredient: Ustekinumab
View notice details →Plan supply. Connect sourcing and warehousing.
For pharmacies, wholesalers and manufacturers: choose the service matching your operational need.
Improve sourcing and supply availability
Researching this shortage professionally? We assess sourcing routes, suppliers and cross-border supply against your requirements. A notice does not confirm stock availability.
Send a sourcing enquiry →Pharma warehouse and pharmaceutical warehousing in Cheb
Medicine storage, batch and expiry control, picking and distribution for Germany and Europe. We agree the storage profile, temperature and capacity with you.
Request warehouse capacity →